Sagimet Biosciences Inc. - Series A Common Stock (NQ:SGMT)
Price and Volume
Detailed Quote| Volume | 33 |
| Open | 6.460 |
| Bid (Size) | 6.150 (100) |
| Ask (Size) | 6.460 (7,700) |
| Prev. Close | 6.460 |
| Today's Range | 6.460 - 6.460 |
| 52wk Range | 1.730 - 11.41 |
| Shares Outstanding | 30,674,855 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Sagimet Biosciences Tops Q2 EPS Forecast ↗
August 13, 2025
Here are the top movers in Thursday's session. ↗
June 12, 2025
These stocks are moving in today's pre-market session ↗
June 04, 2025
Frequently Asked Questions
Is Sagimet Biosciences Inc. - Series A Common Stock publicly traded?
Yes, Sagimet Biosciences Inc. - Series A Common Stock is publicly traded.
What exchange does Sagimet Biosciences Inc. - Series A Common Stock trade on?
Sagimet Biosciences Inc. - Series A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Sagimet Biosciences Inc. - Series A Common Stock?
The ticker symbol for Sagimet Biosciences Inc. - Series A Common Stock is SGMT on the Nasdaq Stock Market
What is the current price of Sagimet Biosciences Inc. - Series A Common Stock?
The current price of Sagimet Biosciences Inc. - Series A Common Stock is 6.460
When was Sagimet Biosciences Inc. - Series A Common Stock last traded?
The last trade of Sagimet Biosciences Inc. - Series A Common Stock was at 12/03/25 04:00 PM ET
What is the market capitalization of Sagimet Biosciences Inc. - Series A Common Stock?
The market capitalization of Sagimet Biosciences Inc. - Series A Common Stock is 198.16M
How many shares of Sagimet Biosciences Inc. - Series A Common Stock are outstanding?
Sagimet Biosciences Inc. - Series A Common Stock has 198M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.